title: [Blood platelets].
abstract: Studies of inherited platelet disorders have led to major advances in our knowledge of platelet physiology, thus permitting the development of antiplatelet agents that are now widely used to treat vascular diseases. New therapeutic strategies have also resulted from a better understanding of megakaryocytopoiesis, notably including the use of thrombopoietin analogs for immune thrombocytopenias.
authors.forename: Jacques
authors.initials: J
authors.lastname: Caen
authors.forename: Sylvia
authors.initials: S
authors.lastname: Bellucci
mesh_terms: D001791:Blood Platelet Disorders / Q000188:drug therapy* / Q000235:genetics / Q000266:history; D001792:Blood Platelets / Q000502:physiology; D049673:History, 20th Century; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*
chemical_list: D010975:Platelet Aggregation Inhibitors